Direct-acting antiviral Therapy Is Safe and Effective in Pediatric Chronic Hepatitis C: The Public Health Perspective

Journal of Pediatric Gastroenterology and Nutrition
Radha K DhimanSandeep Satsangi

Abstract

We assessed the efficacy of decentralized public health services and safety of direct-acting antiviral agents (DAAs) in the treatment of pediatric chronic hepatitis C (CHC) in the Mukh-Mantri Punjab Hepatitis C Relief Fund, a public-health initiative for prevention and control of CHC in Punjab, India. Consecutive children with CHC [age ≥12 to <18 years; both treatment-naïve (TN) and treatment-experienced (TE)] were enrolled. Genotyping was not recommended for non-cirrhotic patients and were treated with sofosbuvir (SOF)+ daclatasvir (DCV) for 12 weeks, while genotyping was recommended for patients with cirrhosis. Patients with cirrhosis and genotype (G2) were treated with SOF+DCV+ribavirin (RBV) for 12 weeks, G3 with SOF+DCV+RBV for 24 weeks and G1, 4, 5, and 6 patients were treated with SOF+ledipasvir (LDV)+RBV for 12 weeks. Treatment duration was increased to 24 weeks if RBV was not tolerated. In the first 16 months (June 18, 2016-October 31, 2017), 88 children (mean age 15.8 years; 69.3.3% boys, 72.3% rural) were enrolled. The mean baseline hepatitis C virus RNA log10 IU/mL was 6.0 (range 4.2-7.5 log10 IU/mL), 65.5% with G3, and 2 (2.5%) with cirrhosis. Of 57 with completed treatment, sustained virological response (SVR) 12 ...Continue Reading

Associated Clinical Trials

References

Mar 8, 2000·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·D ConteE Minola
Jan 23, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Paloma JaraFlavia Bortolotti
Oct 7, 2005·Journal of Clinical Microbiology·Nick A AntonishynGreg B Horsman
Jun 27, 2006·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Neal R BarshesJohn A Goss
Jun 15, 2007·World Journal of Gastroenterology : WJG·Manal A El-HawaryHanaa El-Karaksy
Jan 2, 2008·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Zachary D GoodmanKathleen B Schwarz
Feb 22, 2008·Journal of Gastroenterology and Hepatology·Andreas NydeggerWinita Hardikar
Apr 29, 2008·Gastroenterology·Flavia BortolottiUNKNOWN Italian Observatory for HCV Infection and Hepatitis C in Children
Feb 27, 2009·Journal of Pediatric Gastroenterology and Nutrition·James R RodrigueRegino P González-Peralta
May 5, 2009·Journal of Pediatric Gastroenterology and Nutrition·Regino P González-PeraltaKathleen B Schwarz
Jun 3, 2011·The New England Journal of Medicine·Sanjeev AroraClifford Qualls
Mar 3, 2012·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Maureen M JonasChristopher Duggan
Apr 11, 2012·Journal of Pediatric Gastroenterology and Nutrition·Cara L MackUNKNOWN North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition
Jun 2, 2012·Indian Journal of Community Medicine : Official Publication of Indian Association of Preventive & Social Medicine·Savanna Reid
Dec 7, 2013·World Journal of Gastroenterology : WJG·Mortada Hassan El-Shabrawi, Naglaa Mohamed Kamal
Jan 17, 2014·The New England Journal of Medicine·Mark S SulkowskiUNKNOWN AI444040 Study Group
Jun 26, 2015·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·UNKNOWN AASLD/IDSA HCV Guidance Panel
Jul 19, 2016·Advances in Pediatrics·Yen H Pham, Philip Rosenthal
Sep 27, 2016·Journal of Hepatology·UNKNOWN European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu
Oct 18, 2016·Journal of Clinical and Experimental Hepatology·Radha K DhimanPankaj Puri
Nov 12, 2016·Journal of Pediatric Nursing·Rachel A AnnunziatoRonen Arnon
Dec 21, 2016·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·William F BalistreriKathleen Schwarz
Jan 11, 2017·Alimentary Pharmacology & Therapeutics·A ElsharkawyG Esmat
Apr 1, 2012·WHO South-East Asia Journal of Public Health·Narendra K Arora
Sep 19, 2017·Journal of Gastroenterology and Hepatology·Ramit MahajanAjit Sood
Oct 4, 2017·Journal of Clinical and Experimental Hepatology·Aabha NagralRashid Merchant
Oct 4, 2017·Journal of Clinical and Experimental Hepatology·Madhumita PremkumarRadha K Dhiman
Feb 7, 2018·Hepatology Communications·James E Squires, William F Balistreri
Feb 16, 2018·BMJ Innovations·Clíona Ní CheallaighUNKNOWN Irish Hepatitis C Outcomes Research Network

❮ Previous
Next ❯

Citations

Sep 14, 2019·The American Journal of Tropical Medicine and Hygiene·Belaynew Wasie Taye
Jun 12, 2020·Seminars in Liver Disease·Manal H El-Sayed, Giuseppe Indolfi
Jul 20, 2019·Current Treatment Options in Gastroenterology·Radha K DhimanMadhumita Premkumar
Aug 19, 2020·Journal of Pediatric Gastroenterology and Nutrition·Daniele SerrantiGiuseppe Indolfi
Jan 26, 2021·Clinical Liver Disease·Radha K Dhiman, Madhumita Premkumar
Jul 23, 2021·Journal of Cancer Education : the Official Journal of the American Association for Cancer Education·Melissa Lopez VaronSanjeev Arora

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.